Bridgeway Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.94 - $20.98 $706,260 - $1.66 Million	-79,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $292,600 - $529,320	44,000 Added 125.71%	79,000 $867,000
Q2 2019 Aug 14, 2019	BUY	$4.9 - $9.31 $171,500 - $325,850	35,000 New	35,000 $326,000
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $366,480 - $857,156	-101,800 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.33 - $8.08 $324,729 - $414,504	51,300 Added 101.58%	101,800 $823,000
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $550,450 - $642,865	50,500	50,500 $591,000

232

96.9M

1.39M

543K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $927M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.